StockData
Geron Corp logo

Geron Corp (GERN) stock

GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$1.00+0.06 (+6.17%)

Close on Nov 17, 2026Market cap $642.47MP/E –Yield –

Geron total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Geron's total debt was $120.13M at Jun 30, 2026. For fiscal 2025 it was $119.55M, up 0.9% from the year before. The highest annual figure on record is $119.55M in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$119.55M+0.9%
FY2024Dec 31, 2024$118.48M+44.6%
FY2023Dec 31, 2023$81.94M+60.2%
FY2022Dec 31, 2022$51.16M+2.7%
FY2021Dec 31, 2021$49.83M+107.3%
FY2020Dec 31, 2020$24.04M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$120.13M+1.0%
Q1 FY2026Mar 31, 2026$119.83M+0.9%
Q4 FY2025Dec 31, 2025$119.55M+0.9%
Q3 FY2025Sep 30, 2025$119.26M+42.3%
Q2 FY2025Jun 30, 2025$118.99M+42.6%
Q1 FY2025Mar 31, 2025$118.73M+43.5%
Q4 FY2024Dec 31, 2024$118.48M+44.6%
Q3 FY2024Sep 30, 2024$83.84M+61.5%
Q2 FY2024Jun 30, 2024$83.44M+61.6%
Q1 FY2024Mar 31, 2024$82.75M+61.0%
Q4 FY2023Dec 31, 2023$81.94M+60.2%
Q3 FY2023Sep 30, 2023$51.90M+2.2%
Q2 FY2023Jun 30, 2023$51.64M+2.4%
Q1 FY2023Mar 31, 2023$51.40M+2.4%
Q4 FY2022Dec 31, 2022$51.16M+2.7%
Q3 FY2022Sep 30, 2022$50.76M+46.4%
Q2 FY2022Jun 30, 2022$50.42M+46.5%
Q1 FY2022Mar 31, 2022$50.18M+107.2%
Q4 FY2021Dec 31, 2021$49.83M+107.3%
Q3 FY2021Sep 30, 2021$34.67M+45.1%
Q2 FY2021Jun 30, 2021$34.42M–
Q1 FY2021Mar 31, 2021$24.22M–
Q4 FY2020Dec 31, 2020$24.04M–
Q3 FY2020Sep 30, 2020$23.89M–

More Geron figures

See a number that looks wrong?